STOCK TITAN

American Oncology Network Launches Cloud-Based Laboratory Information System to Streamline Pathology Reporting for Oncologists

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

American Oncology Network (AON) has launched LabVizor (LV), an advanced cloud-based anatomic pathology laboratory information system developed by SigmaCore. This HIPAA-compliant system, designed specifically for oncologists and pathologists, integrates complex pathology reports into a streamlined, comprehensive system.

LabVizor is the result of over 12 years of development by industry experts, including hematopathologist Dr. Aamir Ehsan and Atiq Malik, Executive Vice President of IT at SigmaCore. The platform is fully integrated with AON's electronic medical record system, enabling bidirectional data exchange.

Key features include:

  • Pre-Accessioning for improved workflow planning
  • Integrated Reporting of complex diagnostic information
  • User-Friendly Dashboard with comprehensive lab operations view
  • Data Analytics supporting clinical guidelines
  • Collaboration Tools for effective workflow management

This integration aligns with AON's mission to provide efficient, high-quality oncology services and improve patient care.

American Oncology Network (AON) ha lanciato LabVizor (LV), un avanzato sistema di gestione delle informazioni di laboratorio di anatomia patologica basato su cloud, sviluppato da SigmaCore. Questo sistema conforme a HIPAA, progettato specificamente per oncologi e patologi, integra rapporti patologici complessi in un sistema semplificato e completo.

LabVizor è il risultato di oltre 12 anni di sviluppo da parte di esperti del settore, tra cui il ematopatologo Dr. Aamir Ehsan e Atiq Malik, Vice Presidente Esecutivo IT di SigmaCore. La piattaforma è completamente integrata con il sistema di cartelle cliniche elettroniche di AON, consentendo uno scambio bidirezionale di dati.

Le caratteristiche principali includono:

  • Pre-Accessioning per una pianificazione del flusso di lavoro migliorata
  • Reporting Integrato di informazioni diagnostiche complesse
  • Dashboard Intuitiva con una vista completa delle operazioni di laboratorio
  • Analisi dei Dati a supporto delle linee guida cliniche
  • Strumenti di Collaborazione per una gestione efficace del flusso di lavoro

Questa integrazione è in linea con la missione di AON di fornire servizi oncologici efficienti e di alta qualità e migliorare la cura dei pazienti.

American Oncology Network (AON) ha lanzado LabVizor (LV), un avanzado sistema de información de laboratorio de patología anatómica basado en la nube, desarrollado por SigmaCore. Este sistema, que cumple con HIPAA, está diseñado específicamente para oncólogos y patólogos, e integra informes patológicos complejos en un sistema simplificado y completo.

LabVizor es el resultado de más de 12 años de desarrollo por parte de expertos de la industria, incluidos el hematopatólogo Dr. Aamir Ehsan y Atiq Malik, Vicepresidente Ejecutivo de TI en SigmaCore. La plataforma está completamente integrada con el sistema de registros médicos electrónicos de AON, permitiendo un intercambio bidireccional de datos.

Las características clave incluyen:

  • Pre-Acceso para una mejor planificación del flujo de trabajo
  • Informes Integrados de información diagnóstica compleja
  • Panel de Control Amigable con una vista completa de las operaciones de laboratorio
  • Analítica de Datos que apoya las guías clínicas
  • Herramientas de Colaboración para una gestión efectiva del flujo de trabajo

Esta integración está alineada con la misión de AON de proporcionar servicios de oncología eficientes y de alta calidad, y mejorar la atención al paciente.

미국 종양학 네트워크(AON)LabVizor (LV)를 출시했습니다. 이는 SigmaCore에서 개발한 클라우드 기반의 고급 해부병리학 실험실 정보 시스템입니다. 이 HIPAA 준수 시스템은 종양학자와 병리학자를 위해 특별히 설계되었으며, 복잡한 병리 보고서를 통합하여 간소화된 포괄적 시스템으로 제공합니다.

LabVizor는 혈액병리학자 Dr. Aamir Ehsan와 SigmaCore의 IT 부문 부사장 Atiq Malik을 포함한 업계 전문가들의 12년 이상의 개발 결과물입니다. 이 플랫폼은 AON의 전자 의료 기록 시스템과 완전히 통합되어 데이터의 양방향 교환을 가능하게 합니다.

주요 기능은 다음과 같습니다:

  • 워크플로우 계획 개선을 위한 사전 접수
  • 복잡한 진단 정보의 통합 보고
  • 실험실 운영을 포괄적으로 보여주는 사용자 친화적인 대시보드
  • 임상 가이드를 지원하는 데이터 분석
  • 효과적인 워크플로우 관리를 위한 협업 도구

이 통합은 효율적이고 고품질의 종양학 서비스를 제공하고 환자 치료를 개선하겠다는 AON의 사명과 일치합니다.

American Oncology Network (AON) a lancé LabVizor (LV), un système d'information de laboratoire en pathologie anatomique avancé basé sur le cloud, développé par SigmaCore. Ce système conforme à la HIPAA, conçu spécifiquement pour les oncologues et pathologistes, intègre des rapports pathologiques complexes dans un système rationalisé et complet.

LabVizor est le résultat de plus de 12 ans de développement par des experts de l'industrie, y compris l'hématopathologiste Dr. Aamir Ehsan et Atiq Malik, Vice-Président Exécutif des TI chez SigmaCore. La plateforme est entièrement intégrée au système de dossiers médicaux électroniques d'AON, permettant un échange de données bidirectionnel.

Les principales caractéristiques incluent :

  • Pré-accès pour une meilleure planification des flux de travail
  • Rapports intégrés d'informations diagnostiques complexes
  • Tableau de bord convivial avec une vue d'ensemble complète des opérations de laboratoire
  • Analyse des données soutenant les directives cliniques
  • Outils de collaboration pour une gestion efficace des flux de travail

Cette intégration est en accord avec la mission d'AON de fournir des services d'oncologie efficaces et de haute qualité et d'améliorer les soins aux patients.

American Oncology Network (AON) hat LabVizor (LV) eingeführt, ein fortschrittliches cloud-basiertes System zur Verwaltung von Informationen im Bereich der anatomischen Pathologie, entwickelt von SigmaCore. Dieses HIPAA-konforme System, das speziell für Onkologen und Pathologen entwickelt wurde, integriert komplexe pathologische Berichte in ein vereinfachtes und umfassendes System.

LabVizor ist das Ergebnis von über 12 Jahren Entwicklung durch Branchenexperten, darunter der Hämatopathologe Dr. Aamir Ehsan und Atiq Malik, Executive Vice President für IT bei SigmaCore. Die Plattform ist vollständig in das elektronische Patientenakten-System von AON integriert, was einen bidirektionalen Datenaustausch ermöglicht.

Zu den Hauptmerkmalen gehören:

  • Pre-Accessioning zur Verbesserung der Workflow-Planung
  • Integrierte Berichterstattung über komplexe diagnostische Informationen
  • Benutzerfreundliches Dashboard mit umfassendem Überblick über die Laborabläufe
  • Datenanalyse zur Unterstützung klinischer Richtlinien
  • Zusammenarbeitstools für ein effektives Workflow-Management

Diese Integration steht im Einklang mit AONs Mission, effiziente, hochwertige Onkologie-Dienstleistungen anzubieten und die Patientenversorgung zu verbessern.

Positive
  • Cloud-based system offers scalability and flexibility for network growth
  • Fully integrated with AON's EMR system enabling bidirectional data exchange
  • Improves diagnostic accuracy and workflow efficiency
  • HIPAA-compliant system designed specifically for oncology needs
  • Provides data analytics supporting clinical guidelines and revenue monitoring
Negative
  • None.

SigmaCore’s easy-to-use platform, LabVizor integrates complex pathology reports into a streamlined, comprehensive system to enhance efficiency for AON’s pathology and oncology labs

FORT MYERS, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, is proud to announce the launch of LabVizor (LV), an advanced cloud-based anatomic pathology laboratory information system (LIS) developed by pathology practice management consultancy, SigmaCore. This marks a significant milestone in AON’s ongoing commitment to delivering pathology solutions to improve cancer diagnosis, reporting, and patient care.

LabVizor, the product of over 12 years of development by industry experts, is a HIPAA-compliant LIS designed specifically for the unique needs of oncologists and pathologists. Founded by hematopathologist Dr. Aamir Ehsan and Atiq Malik, Executive Vice President of IT at SigmaCore, LabVizor offers an easy-to-use platform that integrates complex pathology reports into a streamlined, comprehensive system for hematopathology and oncology, focusing on operational excellence and efficiency for pathology and oncology labs worldwide.

“We are thrilled that AON has chosen LabVizor to enhance its diagnostic workflows,” said Dr. Aamir Ehsan, CEO of SigmaCore. “Our platform is designed to improve operational efficiency across all levels – from the lab to clinical decision-making – and we are excited to see how AON’s teams will benefit from its seamless integration, whether it’s an oncologist reviewing test results or a laboratory manager optimizing workflows.”

LabVizor is fully integrated with AON’s electronic medical record (EMR) system, enabling bidirectional data exchange. This integration allows oncology teams to access complex and individual reports with ease, including those for bone marrow morphology, digital pathology, flow cytometry, cytogenetics, FISH analysis, and Next-Generation Sequencing (NGS). These reports are presented in an intuitive, easy-to-read format, helping oncologists make faster and more accurate clinical decisions. With its cloud-based infrastructure, LabVizor offers scalability and flexibility, ensuring that AON’s network can continue to evolve and grow.

Key features of LabVizor include:

  • Pre-Accessioning: A powerful feature that helps laboratories plan workflows and improve sample accountability, reducing the risk of lost samples.
  • Integrated Reporting: Seamless presentation of complex diagnostic information, from test orders and add-ons to detailed reports and results.
  • User-Friendly Dashboard: A modern, customizable dashboard that provides users with a comprehensive view of lab operations, including QA metrics, turnaround time (TAT) monitoring, and real-time performance tracking.
  • Prefix based customization of reports
  • Data Analytics: LabVizor offers internal and external data elements that support clinical guidelines, revenue monitoring, and clinical trial insights, empowering users to generate meaningful data-driven reports.
  • Collaboration Tools: Built-in chat and comment features, co-signatures, and easy communication among team members for more effective workflow management.

“AON is committed to leveraging cutting-edge technology to enhance cancer care and streamline workflows for our providers,” said AON CEO Todd Schonherz. “Integrating LabVizor aligns with our mission to provide efficient, high-quality, patient-centered oncology services. By equipping our teams with this advanced system, we are improving diagnostic accuracy and ensuring oncologists have seamless access to critical pathology insights, ultimately benefiting the patients we serve.”

“We are delighted to announce the integration of LabVizor,” said Mark Moch, American Oncology Network’s chief information officer. “Launching a laboratory information system that utilizes the latest advanced technology to improve cancer diagnosis, reporting, and patient care is a significant milestone in our ongoing commitment to expanding access to high-quality, patient-first cancer care in local communities nationwide.”

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About SigmaCore
SigmaCore is a pathology practice management consultancy that offers a unique and innovative approach to empowering pathologists – whether working solo or in small or large group practices. SigmaCore has created a platform by pathologists for pathologists to build, manage and optimize pathology practices everywhere. For more information, please visit Sigmacore.us.

About LabVizor
LabVizor is a cloud-based anatomic pathology laboratory information system (LIS) designed to meet the needs of pathologists and oncologists. Developed by SigmaCore, LabVizor combines advanced diagnostic reporting, seamless integration with EMRs, and powerful data analytics to support healthcare providers in delivering superior cancer care. As the flagship product of SigmaCore, LabVizor underscores the company’s commitment to delivering LIS solutions that meet the evolving needs of modern pathology and oncology. For more information, please visit sigmacore.us/lab-informatics/.

Media Contacts

SigmaCore
Celina Perkins
cperkins@sigmacore.us | 210-355-1284

American Oncology Network
Karen Riley Sawyer
Karen.sawyer@AONcology.com | 541-221-1472


FAQ

What is LabVizor and how will it benefit AONC's pathology reporting?

LabVizor is a cloud-based anatomic pathology laboratory information system that streamlines complex pathology reports into a comprehensive system. It benefits AONC by enabling bidirectional data exchange with their EMR, presenting reports in an intuitive format, and helping oncologists make faster, more accurate clinical decisions.

When did American Oncology Network (AONC) launch the LabVizor system?

American Oncology Network launched the LabVizor system on February 25, 2025, as part of their commitment to delivering improved pathology solutions for cancer diagnosis, reporting, and patient care.

What specific features does LabVizor offer to AONC's oncology practices?

LabVizor offers AONC's practices pre-accessioning for workflow planning, integrated reporting of complex diagnostics, a customizable dashboard for tracking lab operations, data analytics for clinical guidelines and revenue monitoring, and collaboration tools for team communication.

How does LabVizor integrate with AONC's existing medical record systems?

LabVizor is fully integrated with AONC's electronic medical record system, enabling bidirectional data exchange. This allows oncology teams to easily access complex reports including bone marrow morphology, digital pathology, flow cytometry, cytogenetics, FISH analysis, and Next-Generation Sequencing.

Who developed the LabVizor system being implemented by AONC?

LabVizor was developed by SigmaCore, a pathology practice management consultancy. It was created by hematopathologist Dr. Aamir Ehsan (CEO of SigmaCore) and Atiq Malik (Executive VP of IT at SigmaCore) after over 12 years of development.

American Oncology Network

OTC:AONC

AONC Rankings

AONC Latest News

AONC Stock Data

17.05M
7.61M
18.8%
0.09%
0.11%
Medical Care Facilities
Services-health Services
Link
United States
FORT MYERS